Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Phase 1/2 Trial of Subcutaneously Administered Factor IX Variant CB2679d/ISU304: Pharmacokinetics and Activity

Chur Woo You, MDPhD, Ho-Jin Shin, MD, Howard Levy, MBBCh, PhD, Martin Lee, PhD, Seung-Beom Hong, PhD, Jamie Ellen Siegel, MD, June Young Park, MD

Blood (2017) 130 (Supplement 1): 87.

https://doi.org/10.1182/blood.V130.Suppl_1.87.87

Published: 2017

Journal Articles

Pharmacokinetics of Intravenous Infusion of Glu-Plasminogen Concentrate in Patients with Hypoplasminogenemia

Brandon M. Hardesty, MD, Stacy Plum, PhD, Karen Thibaudeau, PhD, Martin Lee, PhD, Amy D. Shapiro, MD

Blood (2015) 126 (23): 3498.

https://doi.org/10.1182/blood.V126.23.3498.3498

Published: 2015

Journal Articles

Acquired Hemophilia A in an African-American Male After Stem Cell Transplant for Sickle Cell Disease: Successful Treatment with Recombinant Porcine Factor VIII (OBI-1) and Tolerance Induction with Rituximab and Prednisone

Jay N. Lozier, MD, PhD, Khanh Nghiem, BS, Martin Lee, PhD, Bonnie Hodsdon, BS, Galen Joe, MD, R. Patrick Weitzel, PhD, John F. Tisdale, MD, Matthew Hsieh, MD

Blood (2012) 120 (21): 4631.

https://doi.org/10.1182/blood.V120.21.4631.4631

Published: 2012

Journal Articles

IB1001, an Investigational Recombinant Factor IX, Pharmacokinetics in Pediatric Patients with Hemophilia B.

Edward D. Gomperts, MD, Shashikant Apte, MD, Utpal Chaudhuri, MD, Joseph M John, MD, Vijay Ramanan, MD, Ri Liesner, MA MBBChir MD FRCP FRCPath MRCPCH, Amy D. Shapiro, MD, Bonnie J. Mills, PhD, Martin Lee, PhD

Blood (2012) 120 (21): 2225.

https://doi.org/10.1182/blood.V120.21.2225.2225

Published: 2012

Journal Articles

Pharmacokinetic Behavior of IB1001, An Investigational Recombinant Factor IX, in Patients with Hemophilia B: Repeat Pharmacokinetic Study and Subgroup Analysis

Uri Martinowitz, MD, Amy D. Shapiro, MD, Doris V. Quon, MD, PhD, Miguel Antonio Escobar, MD, Christine L Kempton, MD, MSc, Peter Collins, MD, Pratima Chowdary, MD, Michael Makris, MD, Pier Mannuccio Mannucci, MD, Massimo Morfini, MD, Leonard A. Valentino, MD, Edward D. Gomperts, MD, Martin Lee, PhD

Blood (2011) 118 (21): 2267.

https://doi.org/10.1182/blood.V118.21.2267.2267

Published: 2011

NARROW

Phase 1/2 Trial of Subcutaneously Administered Factor IX Variant CB2679d/ISU304: Pharmacokinetics and Activity

Pharmacokinetics of Intravenous Infusion of Glu-Plasminogen Concentrate in Patients with Hypoplasminogenemia

Acquired Hemophilia A in an African-American Male After Stem Cell Transplant for Sickle Cell Disease: Successful Treatment with Recombinant Porcine Factor VIII (OBI-1) and Tolerance Induction with Rituximab and Prednisone

IB1001, an Investigational Recombinant Factor IX, Pharmacokinetics in Pediatric Patients with Hemophilia B.

Pharmacokinetic Behavior of IB1001, An Investigational Recombinant Factor IX, in Patients with Hemophilia B: Repeat Pharmacokinetic Study and Subgroup Analysis

Email alerts

ASH Publications

American Society of Hematology

Phase 1/2 Trial of Subcutaneously Administered Factor IX Variant CB2679d/ISU304: Pharmacokinetics and Activity

Pharmacokinetics of Intravenous Infusion of Glu-Plasminogen Concentrate in Patients with Hypoplasminogenemia

Acquired Hemophilia A in an African-American Male After Stem Cell Transplant for Sickle Cell Disease: Successful Treatment with Recombinant Porcine Factor VIII (OBI-1) and Tolerance Induction with Rituximab and Prednisone

IB1001, an Investigational Recombinant Factor IX, Pharmacokinetics in Pediatric Patients with Hemophilia B.

Pharmacokinetic Behavior of IB1001, An Investigational Recombinant Factor IX, in Patients with Hemophilia B: Repeat Pharmacokinetic Study and Subgroup Analysis

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only